Publications by authors named "Jeff Szer"

100Publications

Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease.

Orphanet J Rare Dis 2020 Oct 13;15(1):284. Epub 2020 Oct 13.

Gaucher Unit, Shaare Zedek Medical Centre, P.O. Box 3235, 91031, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-020-01544-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556970PMC
October 2020

Impact of Gaucher disease on COVID-19.

Intern Med J 2020 Jul;50(7):894-895

Gaucher Unit, Shaare Zedek Medical Centre, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.14894DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405202PMC
July 2020

COVID-19: looking forward.

Authors:
Jeff Szer

Intern Med J 2020 06 29;50(6):657. Epub 2020 Apr 29.

Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.14865DOI Listing
June 2020

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.

N Engl J Med 2020 05 22;382(19):1800-1810. Epub 2020 Apr 22.

From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), the Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck (N.B.), the Department of Hematology and Oncology, University of Leipzig, Leipzig (D.N.), and the Department of Hematology, Oncology, and Pneumology, University Medical Center Mainz, Mainz (E.M.W.) - all in Germany; the Department of Bone Marrow Transplantation, Royal Brisbane and Women's Hospital, Brisbane, QLD (J.B.), and the Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC (J.S.) - all in Australia; Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Sorbonne and INSERM Unité Mixte de Recherche (UMR) 938 (M.M.), and AP-HP, Hématologie-Transplantation, Hôpital St. Louis, Université de Paris and INSERM UMR 976 (G.S.), Paris, and Novartis Pharma, Rueil-Malmaison (B.M.) - all in France; the Cancer Immunotherapy and Immunobiology Research Center, Hadassah University Hospital, Jerusalem (R.O.), and the Hematology Institute and Bone Marrow Transplantation, Clinical Research Institute at Rambam, Rambam Health Care Campus, Haifa (T.Z.) - both in Israel; Novartis Pharmaceuticals, East Hanover, NJ (J.X., K.K.G.); and Novartis Pharma, Basel, Switzerland (C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1917635DOI Listing
May 2020

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage.

Bone Marrow Transplant 2020 10 23;55(10):2043-2044. Epub 2020 Mar 23.

Anthony Nolan Research Institute Royal Free Hospital & UCL Medical School, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-0873-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091850PMC
October 2020

Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.

Biol Blood Marrow Transplant 2020 Sep 16;26(9):1711-1718. Epub 2020 Mar 16.

Department of Haematology and SCT, St Vincent's Hospital, Darlinghurst, New South Wales, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.03.005DOI Listing
September 2020

Is there no place like home for an allogeneic stem cell transplant?

Authors:
Jeff Szer

Bone Marrow Transplant 2020 May 14;55(5):855-856. Epub 2020 Feb 14.

Clinical Haematology, Peter MacCallum Cancer Centre, The Royal Melbourne Hospital, 305 Grattan, St Parkville, VIC, 3050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-0828-2DOI Listing
May 2020

The QuantiFERON Monitor assay is predictive of infection post allogeneic hematopoietic cell transplantation.

Transpl Infect Dis 2020 Jun 29;22(3):e13260. Epub 2020 Feb 29.

University of Melbourne, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tid.13260DOI Listing
June 2020

The Journal in 2019.

Authors:
Jeff Szer

Intern Med J 2020 01;50(1):9-10

Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.14700DOI Listing
January 2020

Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation.

Leuk Lymphoma 2020 01 7;61(1):185-188. Epub 2019 Aug 7.

Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2019.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2019.1648803DOI Listing
January 2020

The Journal in 2018.

Authors:
Jeff Szer

Intern Med J 2019 01;49(1):7-8

Clinical Haematology, Peter MacCallum Cancer Centre, and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/imj.14189
Publisher Site
http://dx.doi.org/10.1111/imj.14189DOI Listing
January 2019

Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation.

Bone Marrow Transplant 2019 06 3;54(6):858-866. Epub 2018 Oct 3.

Integrated Haematology Department, Victorian Comprehensive Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0350-y
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0350-yDOI Listing
June 2019

Rapid intravenous infusion of velaglucerase-alfa in adults with type 1 Gaucher disease.

Am J Hematol 2018 09 9;93(9):E246-E248. Epub 2018 Aug 9.

Gaucher Unit, Shaare Zedek Medical Center, affiliated with Hadassah-Hebrew University Medical School, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25205DOI Listing
September 2018

Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation.

Bone Marrow Transplant 2019 02 14;54(2):175-189. Epub 2018 Jun 14.

Clinical Haematology and Bone Marrow Transplantation, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0244-zDOI Listing
February 2019

Selected state of the art research in internal medicine, 2017.

Intern Med J 2018 06;48(6):619-623

Bone Marrow Transplant Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13820DOI Listing
June 2018

How we manage Gaucher Disease in the era of choices.

Br J Haematol 2018 08 29;182(4):467-480. Epub 2018 May 29.

Gaucher Clinic, Shaare Zedek Medical Centre, Hadassah-Hebrew University Medical School, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15402DOI Listing
August 2018

Prognostic markers in core-binding factor AML and improved survival with multiple consolidation cycles of intermediate-/high-dose cytarabine.

Eur J Haematol 2018 May 2. Epub 2018 May 2.

Department of Clinical Haematology and Bone Marrow Transplant, Royal Melbourne Hospital, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13089DOI Listing
May 2018

Addressing Ethical and Procedural Principles for Unrelated Allogeneic Hematopoietic Progenitor Cell Donation in a Changing Medical Environment.

Biol Blood Marrow Transplant 2018 05 2;24(5):887-894. Epub 2018 Feb 2.

Integrated Departament of Clinical Haematology, Victorian Comprehensive Cancer Centre, Royal Melbourne Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.01.018DOI Listing
May 2018

The Journal in 2017.

Authors:
Jeff Szer

Intern Med J 2018 01;48(1):7-8

Integrated Haematology Department, Victorian Comprehensive Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/imj.13675
Publisher Site
http://dx.doi.org/10.1111/imj.13675DOI Listing
January 2018

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J Clin Oncol 2017 Dec 17;35(36):4003-4011. Epub 2017 Oct 17.

Robert J. Soiffer, Haesook T. Kim, Vincent T. Ho, Edwin P. Alyea, and Jerome Ritz, Dana-Farber Cancer Institute; James D. Levine, Beth Israel Deaconess Medical Center and Harvard Medical School; Yi-Bin Chen, Massachusetts General Hospital, Boston; Frank Glavin, Neovii Biotech, Lexington, MA; Joseph McGuirk, University of Kansas Medical Center, Kansas City, KS; Mitchell E. Horwitz, Duke University Medical Center, Durham; Thomas C. Shea, University of North Carolina School of Medicine, Chapel Hill, NC; Laura Johnston, Stanford University, Stanford, CA; Mrinal M. Patnaik, Mayo Clinic, Rochester, MN; Witold Rybka, Penn State College of Medicine, Hershey; David L. Porter, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Andrew Artz, University of Chicago, Chicago; Patrick J. Stiff, Loyola University Medical Center, Maywood, IL; Michael W. Boyer, University of Utah, Salt Lake City, UT; Richard T. Maziarz, Oregon Health & Science University, Portland, OR; Paul J. Shaughnessy, Texas Transplant Institute, San Antonio; Madhuri Vusirikala, University of Texas Southwestern Medical Center, Dallas, TX; Usama Gergis, Weill Cornell Medical College; Ran Reshef, Columbia University Medical Center, New York, NY; Hana Safah, Tulane University, New Orleans, LA; John F. DiPersio and Peter Westervelt, Washington University School of Medicine, St Louis, MO; Jeff Szer, Royal Melbourne Hospital, Parkville, Victoria; Ian D. Lewis, Royal Adelaide Hospital, Adelaide, South Australia, Australia; Jennifer Holter, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Paul J. Martin, Fred Hutchinson Cancer Research Center, Seattle, WA; Joseph A. Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.8177DOI Listing
December 2017

Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New Zealand.

Biol Blood Marrow Transplant 2018 01 28;24(1):169-174. Epub 2017 Sep 28.

Department of Haematology and BMT, Royal Melbourne Hospital, Parkville Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.09.011DOI Listing
January 2018

Should eliglustat be first line therapy for patients with type 1 Gaucher disease? Definitions of safety and efficacy.

Blood Cells Mol Dis 2018 02 14;68:14-16. Epub 2017 Sep 14.

Department of Clinical Haematology, Royal Melbourne Hospital and Victorian Comprehensive Cancer Centre, 300 Grattan St, Parkville, VIC 3050, Australia.. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2017.09.003DOI Listing
February 2018

Recent advances and future challenges in Gaucher disease.

Blood Cells Mol Dis 2018 02 8;68:9-13. Epub 2017 Sep 8.

Royal Melbourne Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2017.08.016DOI Listing
February 2018

Preface to the special issue on Gaucher disease 2017.

Blood Cells Mol Dis 2018 02 8;68:1-2. Epub 2017 Sep 8.

Royal Melbourne Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2017.08.015DOI Listing
February 2018

Economic Challenges in Hematopoietic Cell Transplantation: How Will New and Established Programs Face the Growing Costs?

Biol Blood Marrow Transplant 2017 11 7;23(11):1815-1816. Epub 2017 Aug 7.

Royal Melbourne Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.07.026DOI Listing
November 2017

Clinical course and disease burden in patients with paroxysmal nocturnal hemoglobinuria by hemolytic status.

Blood Cells Mol Dis 2017 06 27;65:29-34. Epub 2017 Mar 27.

Royal Melbourne Hospital, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2017.03.013DOI Listing
June 2017

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

J Clin Oncol 2017 May 3;35(15):1678-1685. Epub 2017 Apr 3.

Kenneth F. Bradstock and Warwick Benson, Westmead Hospital, University of Sydney; Arno Enno, Sandra Deveridge, and Philip Rowlings, Calvary Mater Newcastle Hospital, Newcastle; Luke Coyle, Royal North Shore Hospital, St Leonards; Campbell Tiley, Central Coast Health, Gosford; John Moore, St Vincent's Hospital; Mark Hertzberg, Prince of Wales Hospital, Sydney; Kimberly Cartwright, Wollongong Hospital, Wollongong; Ilona Cunningham, Concord Repatriation General Hospital, Concord; John Taper, Nepean Hospital, Penrith, New South Wales; Emma Link, Juliana Di Iulio, and John F. Seymour, Peter MacCallum Cancer Centre; Jeff Szer, Andrew Grigg, Andrew W. Roberts, and John F. Seymour, University of Melbourne; Andrew H. Wei, Monash University; Anthony Schwarer, Box Hill Hospital; Lynda Campbell, Victorian Cancer Cytogenetics Service, Melbourne; Jeff Szer, Andrew Grigg, and Andrew W. Roberts, Royal Melbourne Hospital, Parkville; Phillip Campbell, Deakin University School of Medicine, Geelong, Victoria; Paula Marlton, Anthony K. Mills, and Devinder Gill, University of Queensland, Brisbane, Queensland; Ray M. Lowenthal, University of Tasmania, Hobart, Tasmania; Ian D. Lewis and Peter Bardy, Royal Adelaide Hospital; Uwe Hahn, Queen Elizabeth Hospital, Adelaide, South Australia; James D'Rozario, The Canberra Hospital, Garran, Canberra, Australia Capital Territory; Gavin Cull, Sir Charles Gairdner Hospital; Michael F. Leahy, University of Western Australia; and Paul Cannell, Royal Perth Hospital, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.6374
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.6374DOI Listing
May 2017

Intraobserver and interobserver variability of the bone marrow burden (BMB) score for the assessment of disease severity in Gaucher disease. Possible impact of reporting experience.

Blood Cells Mol Dis 2018 02 14;68:121-125. Epub 2016 Nov 14.

Parkville Integrated Haematology Serve, The Royal Melbourne Hospital, Grattan St, Parkville, 3050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2016.11.004DOI Listing
February 2018

The Journal in 2016.

Authors:
Jeff Szer

Intern Med J 2017 Jan;47(1):5-6

Internal Medicine Journal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13326DOI Listing
January 2017

Classifying the additional morbidities of Gaucher disease.

Blood Cells Mol Dis 2018 02 19;68:209-210. Epub 2016 Dec 19.

Gaucher Clinic, Department of Medicine, Shaare Zedek Medical Center, Hebrew University and Hadassah Medical School, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2016.12.006DOI Listing
February 2018

Uncommon diagnoses do occur.

Authors:
Jeff Szer

Lancet 2016 Sep;388(10049):1128

Department of Clinical Haematology & BMT Service, The Royal Melbourne Hospital, Melbourne, VIC, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)31014-5DOI Listing
September 2016

Safety of Living Donation of Hematopoietic Stem Cells.

Transplantation 2016 06;100(6):1329-31

1 The Royal Melbourne Hospital, Melbourne, Australia. 2 Canadian Blood Services, Ottowa, ONT, Canada. 3 Europdonor Foundation, Leiden, The Netherlands. 4 Singapore General Hospital and Duke-NUS Graduate Medical School, College Road, Singapore. 5 Cell Therapy Services, Finnish Red Cross Blood Service and Helsinki University Central Hospital, Finland. 6 National Marrow Donor Program, Minneapolis, MN. 7 DKMS German Bone Marrow Donor Center, Köln, Germany. 8 Center for International Blood and Marrow Transplant Research, Milwaukee, MN. 9 Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/transplantjournal/2016/06000/Sa
Web Search
http://dx.doi.org/10.1097/TP.0000000000001223DOI Listing
June 2016

Reprint of: Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States.

Biol Blood Marrow Transplant 2016 Mar;22(3 Suppl):S15-8

Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.01.006DOI Listing
March 2016

Global Use of Peripheral Blood vs Bone Marrow as Source of Stem Cells for Allogeneic Transplantation in Patients With Bone Marrow Failure.

JAMA 2016 Jan;315(2):198-200

Asia Pacific Blood and Marrow Transplant Group Data Centre Nagakute Campus, Aichi Medical University, School of Medicine, Nagakute, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2015.13706DOI Listing
January 2016

Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States.

Biol Blood Marrow Transplant 2016 Jan 10;22(1):23-6. Epub 2015 Nov 10.

Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.11.001DOI Listing
January 2016

A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013.

Biol Blood Marrow Transplant 2016 Feb 16;22(2):284-291. Epub 2015 Sep 16.

Department of Haematology and BMT, Royal Melbourne Hospital, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.009DOI Listing
February 2016

Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.

N Engl J Med 2015 Sep;373(11):1032-9

From Department of Haematology, St. James's University Hospital, Leeds (R.J.K., A.H.), and Haematological Medicine, Kings College Hospital, London (A.K.) - both in the United Kingdom; University of Ulm and German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Ulm (B.H., H.S.), and Department of Hematology, University Hospital of Essen, Essen (A.R.) - both in Germany; PNH Subcommittee of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation, Leiden (B.H., A.K., A.M.R., L.T., H.S., R.P.L.), and Radboud University Medical Center, Nijmegen (P.M.) - both in the Netherlands; Department of Clinical Haematology, the Royal Melbourne Hospital and University of Melbourne, Parkville, VIC, Australia (J.S.); Department of Hematology, University Hospital, Rennes (S.G.), Clinical Immunology, Department of Internal Medicine, University Hospital of Lille, Lille (L.T.), and Assistance Publique-Hôpitaux de Paris, Service d'Hématologie-Greffe, Hôpital Saint-Louis, University Paris Diderot, Sorbonne Paris Cité, Centre de Référence Aplasie Médullaire-HPN, and Filière de Santé Maladie Rare Immuno-Hématologique (MARIH), Paris (R.P.L.) - all in France; Jane Anne Nohl Division of Hematology, Keck School of Medicine of University of Southern California, Los Angeles (I.C.W.); Department of Hematology, Helsinki University Central Hospital, Helsinki (E.A.); Hematology, Department of Clinical Medicine and Surgery, Federico II, University of Naples, Naples, Italy (A.M.R.); Hematology and Thromboembolism, McMaster University, Hamilton, ON, Canada (C.J.P.); and ICON Clinical Research, San Francisco (M.P.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1502950DOI Listing
September 2015

Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool.

Clin Chim Acta 2015 Oct 29;450:6-10. Epub 2015 Jul 29.

Genetics and Molecular Pathology, SA Pathology [at Women's and Children's Hospital], 72 King William Road, North Adelaide, South Australia 5006, Australia; Department of Paediatrics, University of Adelaide, Adelaide, South Australia 5005, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2015.07.026DOI Listing
October 2015

The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia.

Br J Haematol 2015 Feb 1;168(4):576-82. Epub 2014 Oct 1.

Centre for Cancer Research, MIMR-PHI Institute of Medical Research, Clayton, Vic., Australia; Centre for Inflammatory Diseases, Monash University, Clayton, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13151DOI Listing
February 2015

Validating the allogeneic stem cell transplantation disease risk index: sample size, follow-up, and local data are important.

Transplantation 2015 Jan;99(1):128-32

1 Department of Clinical Haematology and Bone Marrow Transplant Service, The Royal Melbourne Hospital, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/TP.0000000000000257DOI Listing
January 2015

Screening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2014 Jun 16;20(6):781-6. Epub 2014 Feb 16.

Department of Clinical Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital, Parkville, Victoria, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.02.011DOI Listing
June 2014

Prognostic impact of monocyte count at presentation in mantle cell lymphoma.

Br J Haematol 2014 Mar 25;164(6):890-3. Epub 2013 Nov 25.

Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12683DOI Listing
March 2014

Chronic neutrophilia associated with myeloma: is it clonal?

Leuk Lymphoma 2014 Feb 8;55(2):439-40. Epub 2013 Jul 8.

Diagnostic Haematology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.809080DOI Listing
February 2014

Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion.

Clin Adv Hematol Oncol 2012 Nov;10(11 Suppl 21):1-16

Department of Clinical Haematology & BMT Service, Royal Melbourne Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
November 2012

A population-based analysis of the effect of autologous hematopoietic cell transplant in the treatment of multiple myeloma.

Leuk Lymphoma 2013 Aug 28;54(8):1671-6. Epub 2013 Jan 28.

Australasian Bone Marrow Transplant Recipient Registry (ABMTRR), Darlinghurst, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.763396DOI Listing
August 2013

The effect of folinic acid on methylenetetrahydrofolate reductase polymorphisms in methotrexate-treated allogeneic hematopoietic stem cell transplants.

Biol Blood Marrow Transplant 2012 May 14;18(5):722-30. Epub 2011 Sep 14.

Department of Pharmaceutical Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.09.001DOI Listing
May 2012

Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk.

Biol Blood Marrow Transplant 2012 Feb 11;18(2):302-8. Epub 2011 May 11.

Australasian Bone Marrow Transplant Registry, 20 Leichhardt St., Darlinghurst, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.05.003DOI Listing
February 2012

The substrate is down: is the IV out?

Authors:
Jeff Szer

Blood 2010 Aug;116(6):860-1

Royal Melbourne Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-05-285163DOI Listing
August 2010

Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy.

Br J Haematol 2010 Jul 7;150(1):39-45. Epub 2010 May 7.

Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2010.08162.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2010.08162.xDOI Listing
July 2010

Hematopoietic stem cell transplantation: a global perspective.

JAMA 2010 Apr;303(16):1617-24

European Group for Blood andMarrow Transplantation, Transplant Activity Survey Office, Department of Hematology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2010.491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219875PMC
April 2010